Tissue penetration of antibiotics: Does the treatment reach the target site?;Gewebepenetration von Antibiotika: Erreicht die Behandlung den Zielort?

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 109, Issue 3, 2014, Pages 175-181

  Lagler, H ^a   Zeitlinger, M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Criticall illness; Microdialysis; Pharmacodynamics; Pharmacokinetics; Target site penetration

Indexed keywords

ANTIBIOTIC AGENT; LEVOFLOXACIN; MEROPENEM; ANTIINFECTIVE AGENT;

ARTICLE; BIOPSY; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; HUMAN TISSUE; LUNG LAVAGE; MICRODIALYSIS; PATHOGENESIS; PLASMA; TISSUES; BACTERIAL INFECTIONS; BIOAVAILABILITY; BLOOD; CRITICAL ILLNESS; CROSS INFECTION; DOSE RESPONSE; DRUG ADMINISTRATION; GERMANY; INTENSIVE CARE UNIT; SEPSIS; TISSUE DISTRIBUTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL AVAILABILITY; CRITICAL ILLNESS; CROSS INFECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GERMANY; HUMANS; INTENSIVE CARE UNITS; SEPSIS; TISSUE DISTRIBUTION;

EID: 84899922436     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-013-0309-0     Document Type: Article

References (41)

1. Andrews JM, Honeybourne D, Jevons G et al (1997) Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother 40: 573-577.
2. Bergogne-Berezin E, Muller-Serieys C, Aubier M et al (1994) Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy. Eur J Clin Pharmacol 46: 87-88.
3. Brun-Buisson C, Meshaka P, Pinton P et al (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30: 580-588.
4. Brunner M, Langer O (2006) Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J 8: E263-E271.
5. Brunner M, Pernerstorfer T, Mayer BX et al (2000) Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 28: 1754-1759.
6. Byl B, Jacobs F, Roucloux I et al (1999) Penetration of meropenem in lung, bronchial mucosa, and pleural tissues. Antimicrob Agents Chemother 43: 681-682.
7. Capitano B, Mattoes HM, Shore E et al (2004) Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 125: 965-973.
8. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26: 1-10 (quiz 11-12).
9. Dagan R, Velghe L, Rodda JL et al (1994) Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. J Antimicrob Chemother 34: 175-179.
10. Davis R, Bryson HM (1994) Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47: 677-700.
11. Elmquist WF, Sawchuk RJ (1997) Application of microdialysis in pharmacokinetic studies. Pharm Res 14: 267-288.
12. EMEA (2000) Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. http://www. tga. gov. au/pdf/euguide/ewp265599en. pdf. Zugegriffen: 17. März 2014.
13. FDA (1998) Guidance for Industry. Developing antimicrobial drugs - general considerations for clinical trials. http://www. fda. gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070983. pdf. Zugegriffen: 17. März 2014.
14. Fish DN, Chow AT (1997) The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 32: 101-119.
15. Frimodt-Moller N (2002) How predictive is PK/PD for antibacterial agents? Int J Antimicrob Agents 19: 333-339.
16. Fujita A, Miya T, Tanaka R et al (1999) Levofloxacin concentrations in serum, sputum and lung tissue: evaluation of its efficacy according to breakpoint. Jpn J Antibiot 52: 661-666.
17. Goncalves-Pereira J, Povoa P (2011) Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams. Crit Care 15: R206.
18. Gotfried MH, Danziger LH, Rodvold KA (2001) Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 119: 1114-1122.
19. Hukagawa H, Noga K (1992) A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients. Jpn J Antibiot 45: 253-257.
20. Joukhadar C, Frossard M, Mayer BX et al (2001) Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29: 385-391.
21. Joukhadar C, Klein N, Mayer BX et al (2002) Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 30: 1478-1482.
22. Karjagin J, Lefeuvre S, Oselin K et al (2008) Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock. Clin Pharmacol Ther 83: 452-459.
23. Kearney BP, Aweeka FT (1999) The penetration of anti-infectives into the central nervous system. Neurol Clin 17: 883-900.
24. Kitzes-Cohen R, Farin D, Piva G et al (2002) Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients. Int J Antimicrob Agents 19: 105-110.
25. Marcy TW, Merrill WW, Rankin JA et al (1987) Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis135: 1276-1280.
26. Nishikawa G, Ikawa K, Nakamura K et al (2013) Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. Int J Antimicrob Agents 41: 267-271.
27. Pea F, Pavan F, Nascimben E et al (2003) Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy. Antimicrob Agents Chemother 47: 3104-3108.
28. Rennard SI, Basset G, Lecossier D et al (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 60: 532-538.
29. Robatel C, Decosterd LA, Biollaz J et al (2003) Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J Clin Pharmacol 43: 1329-1340.
30. Roberts JA, Kirkpatrick CM, Roberts MS et al (2009) Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 64: 142-150.
31. Ryan DM (1993) Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 31(Suppl D): 1-16.
32. Sauermann R, Delle-Karth G, Marsik C et al (2005) Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemother 49: 650-655.
33. Tomaselli F, Maier A, Matzi V et al (2004) Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob Agents Chemother 48: 2228-2232.
34. Vogelman B, Gudmundsson S, Leggett J et al (1988) Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J Infect Dis 158: 831-847.
35. Zeitlinger BS, Zeitlinger M, Leitner I et al (2007) Clinical scoring system for the prediction of target site penetration of antimicrobials in patients with sepsis. Clin Pharmacokinet 46: 75-83.
36. Zeitlinger M, Muller M, Joukhadar C (2005) Lung microdialysis - a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review). Aaps J 7: E600-E608.
37. Zeitlinger MA, Dehghanyar P, Mayer BX et al (2003) Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 47: 3548-3553.
38. Zeitlinger MA, Erovic BM, Sauermann R et al (2005) Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother 56: 703-708.
39. Zeitlinger MA, Traunmuller F, Abrahim A et al (2007) A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung. Int J Antimicrob Agents 29: 44-50.
40. Zhanel GG, Dueck M, Hoban DJ et al (2001) Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 61: 443-498.
41. http://en. wikipedia. org/wiki/File: Schematic_illustration_of_a_microdialysis_probe. png#metadata. Zugegriffen: 17. März 2014.